News & Updates
Filter by Specialty:

COVID-19 variants carry no increased autoimmune sequelae risk
COVID-19 variants delta and omicron BA.1 or BA.2 do not pose a substantial threat of long-term autoimmune complications, except for a modest elevation in inflammatory bowel disease and bullous skin disorders among hospitalized patients during the omicron predominance in Singapore, as shown in a study.
COVID-19 variants carry no increased autoimmune sequelae risk
16 Sep 2024
Fewer CV events after COVID-19 vaccine-related myocarditis
In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.
Fewer CV events after COVID-19 vaccine-related myocarditis
13 Sep 2024
PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
Pulmonary vascular resistance (PVR) may be used to distinguish severe (PVR >4 Wood Units) from nonsevere pulmonary hypertension (PVR ≤4 Wood Units) among patients with bronchiectasis-associated pulmonary hypertension (BAPH) and identify those who are at higher risk of mortality, a study suggests.
PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
04 Sep 2024
Steroid use may increase mortality in acute exacerbation of FILD
A high mortality risk hounds patients with acute exacerbation (AE) of fibrotic interstitial lung disease (FILD) despite treatment with corticosteroids, reports a study, noting that such risk is similar to that seen in those with AE of idiopathic pulmonary fibrosis (IPF).
Steroid use may increase mortality in acute exacerbation of FILD
30 Aug 2024
Spirulina dietary supplement beneficial for COVID-19?
Supplementing standard COVID-19 treatment with Spirulina – a nutrient-rich superfood – may improve recovery and reduce mortality in hospitalized COVID-19 patients, a study from Iran suggests.